The latest news from PTC

Today, July 15, 2023, we’re honoring leiomyosarcoma (LMS) Awareness Day by sharing some firsthand perspectives on the journey living with this rare cancer. LMS is a type of soft-tissue sarcoma, referred to as a malignant smooth muscle tumor, which can arise in several locations within the body. This rare cancer often presents as enlarging masses…

2023 is a meaningful, unique and thrilling year for PTC. It’s the company’s 25th anniversary, and it is poised to be a year of momentum as we anticipate significant trial readouts in multiple disease areas. We’re also working toward our ambitious goal to produce a therapy every two to three years based on our robust…